Stay updated with breaking news from Deepak Bhatt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In an interview at AHA 2023, Deepak Bhatt, MD, MPH, discusses recent advancements in cardiovascular risk management, with a focus on the evolving recognition of inflammation, Lp(a), and obesity as modifiable risk factors.
Researchers report the first results from a study testing the revolutionary gene-editing technique known as CRISPR for cutting high cholesterol.
Researchers report the first results from a study testing the revolutionary gene-editing technique known as CRISPR for cutting high cholesterol.
Researchers report the first results from a study testing the revolutionary gene-editing technique known as CRISPR for cutting high cholesterol.
The weight loss drug showed a consistent reduction in major cardiovascular events over a 3-year follow up in patients with a history of heart disease who were overweight or obese.